BioPharm International
CONTINUE TO SITE >

OR WAIT 15 SECS

Elizabeth S. Retersdorf

Articles

Advocating for Biosimilar Approval Standards Under BPCI

FDA weighs multiple views regarding the Biologics Price Competition and Innovation Act.